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Defining  causal  variation  by  fine-mapping  can  be  more  effective  in  multi-ethnic  genetic 
studies,  particularly  in  regions  such  as  the  MHC  with  highly  population-specific 
structure.  To  enable  such  studies,  we  constructed  a  large  (N=21,546)  high  resolution  HLA 
reference  panel  spanning  five  global  populations  based  on  whole-genome  sequencing 
data.  Expectedly,  we  observed  unique  long-range  HLA  haplotypes  within  each  population 
group.  Despite  this,  we  demonstrated  consistently  accurate  imputation  at  G-group 
resolution  (94.2%,  93.7%,  97.8%  and  93.7%  in  Admixed  African  (AA),  East  Asian  (EAS), 
European  (EUR)  and  Latino  (LAT)).  We  jointly  analyzed  genome-wide  association  studies 
(GWAS)  of  HIV-1  viral  load  from  EUR,  AA  and  LAT  populations.  Our  analysis  pinpointed 
the  MHC  association  to  three  amino  acid  positions  (97,  67  and  156)  marking  three 
consecutive  pockets  (C,  B  and  D)  within  the  HLA-B  peptide  binding  groove,  explaining 
12.9%  of  trait  variance,  and  obviating  effects  of  previously  reported  associations  from 
population-specific  HIV  studies.  
Main 
 
The  HLA  genes  located  within  the  MHC  region  encode  proteins  that  play  essential  roles  in 
immune  responses  including  antigen  presentation.  They  account  for  more  heritability  than  all 
other  variants  together  for  many  diseases 1–4 .  It  also  has  more  reported  GWAS  trait  associations 
than  any  other  locus 5 .  The  extended  MHC  region  spans  6Mb  on  chromosome  6p21.3  and 
contains  more  than  260  genes 6 .  Due  to  population-specific  positive  selection  it  harbors 
unusually  high  sequence  variation,  longer  haplotypes  than  most  of  the  genome,  and  haplotypes 
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that  are  specific  to  individual  ancestral  populations 7,8 .  Consequently,  the  MHC  is  among  the 
most  challenging  regions  in  the  genome  to  analyze.  Advances  in  HLA  imputation  have  enabled 
population-specific  association  and  fine-mapping  studies  of  this  locus 2,9–12 .  But  despite  large 
effect  sizes,  fine-mapping  in  multiple  populations  simultaneously  is  challenging  without  a  single 
large  and  high-resolution  multi-ethnic  reference  panel.  This  has  caused  confusion  in  some 
instances.  For  example,  defining  the  driving  HLA  alleles  may  inform  the  design  of  antigenic 
peptides  for  vaccines 13,14   for  HIV-1,  which  led  to  770,000  deaths  in  2018  alone 15 .  However, 
multiple  risk  HLA  risk  alleles  have  been  independently  reported  in  different  populations 1,10,16 ,  and 
it  is  not  clear  if  they  represent  truly  population-specific  signals  or  are  confounded  by  linkage. 
Results 
Performance  evaluation  of  inferred  classical  HLA  alleles 
To  build  a  large-scale  multi-ethnic  HLA  imputation  reference  panel,  we  used  high-coverage 
whole  genome  sequencing  (WGS)  datasets 17–21   from  the  Japan  Biological  Informatics 
Consortium 20 ,  the  BioBank  Japan  Project 18 ,  the  Estonian  Biobank 22 ,  the  1000  Genomes  Project 
(1KG) 21   and  a  subset  of  studies  in  the  TOPMed  program  ( Supplementary  Note , 
Supplementary  Table  1-2 ).  To  perform  HLA  typing  using  WGS  data,  we  extracted  reads 
mapped  to  the  extended  MHC  region  (chr6:25Mb-35Mb)  and  unmapped  reads  from  24,338 
samples.  We  applied  a  population  reference  graph 23–25 ,   for  the  MHC  region  to  infer  classical 
alleles  for  three  HLA  class  I  genes  (HLA -A,  -B  and  - C )  and  five  class  II  genes  (HLA -DQA1 , 
- DQB1 ,  -DRB1 ,  - DPA1 ,  - DPB1 )  at  G-group  resolution,  which  determines  the  sequences  of  the 
exons  encoding  the  peptide  binding  groove .  We  required  samples  to  have  >20x  coverage 
across  all  HLA  genes  ( Supplementary  Table  1 ,  3 ).  After  quality  control  our  panel  included 
21,546  individuals:  10,187  EUR,  7,849  AA,  2,069  EAS,  952  LAT  and  489  SAS.  
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To  assess  the  accuracy  of  the  WGS  HLA  allele  calls,  we  compared  the  inferred  HLA  classical 
alleles  to  gold  standard  sequence-based  typing  (SBT)  in  955  1KG  subjects  and  288  Japanese 
subjects  and  quantified  concordance.  In  both  cohorts  we  observed  slightly  higher  average 
accuracy  for  class  I  genes,  obtaining  99.0%  (one-field,  formally  known  as  two-digit),  99.2% 
(amino  acid)  and  96.5%  (G-group  resolution),  than  class  II  genes,  obtaining  98.7%  (one-field), 
99.7%  (amino  acid)  and  96.7%  (G-group  resolution,  Methods,  Supplementary  Figure  1 , 
Supplementary  Tables  4-5 ,  Extended  Data  1 ). 
HLA  diversity 
To  quantify  MHC  diversity,  we  calculated  identity-by-descent  (IBD)  distances 26   between  all 
individuals  using  38,398  MHC  single  nucleotide  polymorphisms  (SNPs)  included  in  the 
multi-ethnic  HLA  reference  panel  (N=21,546)  and  applied  principal  component  analysis  (PCA, 
Methods ).  PCA  distinguished  EUR,  EAS  and  AA  as  well  as  the  admixed  LAT  and  SAS  samples 
( Figure  1a ,  Supplementary  Figure  2 ).  This  reflected  widespread  HLA  allele  frequency 
differences  between  populations  ( Figure  1b-c ,  Supplementary  Figure  3 ).  Of  130  unique 
common  (frequency  >  1%)  G-group  alleles,  129  demonstrated  significant  differences  of 
frequencies  across  populations  (4  degree-of-freedom  Chi-square  test,  p-value  <  0.05/130, 
Supplementary  Figure  4 ).  The  only  exception  was  DQA1*01:01:01G  which  was  nominally 
significant  (unadjusted  p-value  =  0.047).  These  differences  may  be  related  to  adaptive  selection. 
For  example,  the  B*53:01:01G  allele  is  enriched  in  Admixed  Africans  (11.7%  in  AA  versus  0.3% 
in  others)  and  it  has  been  previously  associated  with  malaria  protection 27,28 .  Consistent  with 
previous  reports 29,30 ,  we  observed  that  HLA -B  had  the  highest  allelic  diversity  (n=443)  while 
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HLA- DQA1  had  the  least  (n=17,  Supplementary  Figure  5-6 ,  Supplementary  Table  6 , 
Extended  Data  1 ).  
 
To  understand  the  haplotype  structure  of  HLA  between  pairs  of  HLA  genes  we  calculated  a 
multiallelic  linkage  disequilibrium  (LD)  measurement  index 31–33 ,  ,  which  is  0  when  there  is  no ε
LD  and  1  when  there  is  perfect  LD  ( Figure  2a ).  We  observed  higher    between  DQA1 ,  DQB1 , ε
and  DRB1;  between  DPA1  and  DPB1 ;  and  between  B  and  C  ( Supplementary  Figure  7 ).  The 
heterogeneity  between  different  populations  was  underscored  by  the  presence  of 
population-specific  common  (frequency  >1%)  high  resolution  long-range  haplotypes 
(HLA- A~C~B~DRB1~DQA1~DQB1~DPA1~DPB1 ,  Figure  2b,  Supplementary  Figure  8-12 , 
Extended  Data  2,  Methods ).  The  most  common  within-population  haplotype  was  A24::DP6 
(HLA -A*24:02:01G~C*12:02:01G~B*52:01:01G~DRB1*15:02:01G~DQA1*01:03:01G~DQB1*06 
:01:01G~DPA1*02:01:01G~DPB1*09:01:01G )  found  at  a  frequency  of  3.61%  in  EAS 
( Supplementary  Figure  8 ).  This  haplotype  is  strongly  associated  with  immune-mediated  traits 
such  as  HIV 34   and  ulcerative  colitis 35   in  Japanese  individuals.  The  next  most  common  haplotype 
was  the  well-described  European-specific  ancestral  haplotype  A1::DP1  or  8.1 36,37   ( 
frequency=2.76%, 
HLA- A*01:01:01G~C*07:01:01G~B*08:01:01G~DRB1*03:01:01G~DQA1*05:01:01G~DQB1*02: 
01:01G~DPA1*02:01:02G~DPB1*01:01:01G ,  Supplementary  Figure  9 ).  This  haplotype  is 
associated  with  diverse  immunopathological  phenotypes  in  the  European  population,  including 
systemic  lupus  erythematosus 38 ,  myositis 39   and  several  other  conditions 36 .  We  observed 
long-range  haplotypes  in  admixed  populations  including  A1::DP4  in  SAS  (frequency=1.86%, 
Supplementary  Figure  10 ),  A30::DP1  in  AA  (frequency=1.18%, 
HLA -A*30:01:01G~C*17:01:01G~B*42:01:01:G~DRB1*03:02:01G~DQA1*04:01:01G~DQB1*04 
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:02:01G~DPA1*02:02:02G~DPB1*01:01:01G  ,  Supplementary  Figure  11 ),  and  A29::DP11  in 
LAT  (frequency=0.74%, 
HLA -A*29:02:01G~C*16:01:01G~B*44*03:01:G~DRB1*07:01:01G~DQA1*02:01:01G~DQB1*0 
2:01:01G~DPA1*02:01:01G~DPB1*11:01:01G ,  Supplementary  Figure  12 ).  
These  haplotypes  also  have  associations  with  multiple  diseases:  for  example  C*06:02~B*57:01 
is  associated  with  psoriasis 40   and  A*30:01~C*17:01~B*42:01  is  associated  with  HIV 41 . 
HLA  selection  signature 
Previous  studies  have  suggested  that  recent  natural  selection  favors  African  ancestry  in  the 
HLA  region  in  admixed  populations 42–45 .  To  test  this  hypothesis  in  our  data,  we  obtained  WGS 
data  from  a  subset  of  individuals  within  two  admixed  populations  (1,832  AA  and  594  LAT, 
determined  by  the  first  three  global  principal  components,  Supplementary  Figure  13 , 
Supplementary  Note ).  Admixed  individuals  have  genomes  that  are  a  mosaic  of  different 
ancestries.  If  genetic  variations  or  haplotypes  from  an  ancestral  population  are  advantageous, 
then  they  are  under  selection  and  are  expected  to  have  higher  frequency  than  by  chance.  Using 
ELAI 46 ,  we  quantified  how  much  the  ancestry  proportions  differed  within  the  MHC  from  the 
genome-wide  average.  In  AA,  we  observed  that  the  average  genome-wide  proportion  of  African 
ancestry  was  74.5%,  compared  to  78.0%  in  the  extended  MHC  region,  corresponding  to  a  3.42 
(95%  CI:  3.35-3.49)  standard  deviation  increase.  In  LAT,  we  observed  5.76%  African  ancestry 
genome-wide  versus  16.0%  in  the  extended  MHC  region,  representing  an  increase  of  4.23 
(95%  CI:  4.14-4.31)  standard  deviations  ( Methods ,  Supplementary  Figure  14 ).  To  ensure  our 
results  are  robust  to  different  local  ancestry  inference  methods,  we  applied  an  alternative 
method  called  RFMix 47   and  observed  a  similarly  consistent  MHC-specific  excess  of  African 
ancestry  in  LAT,  and  also  an  excess  in  AA  that  was  more  modest  ( Supplementary  Figure  14) .  
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Construction  of  a  multi-ethnic  HLA  reference  panel  and  its  performance  evaluation 
Next,  we  constructed  a  multi-ethnic  HLA  imputation  reference  panel  based  on  classical  HLA 
alleles  and  38,398  genomic  markers  in  the  extended  MHC  region  using  a  novel  HLA-focused 
pipeline  HLA-TAPAS  (HLA-Typing  At  Protein  for  Association  Studies).  Briefly,  HLA-TAPAS  can 
handle  HLA  reference  panel  construction  ( MakeReference );  HLA  imputation  ( SNP2HLA )  and 
HLA  association  ( HLAassoc )  ( Methods ,  URLs ).  Compared  to  a  widely  used  HLA  reference 
panel  with  European-only  individuals  (The  Type  1  Diabetes  Genetics  Consortium 48   ,  T1DGC), 
this  new  reference  panel  has  a  six-fold  increase  in  the  number  of  observed  HLA  alleles  and 
non-HLA  genomic  markers  ( Supplementary  Table  7 ).  We  noted  the  difference  in  observed 
classical  HLA  alleles  is  mainly  due  to  the  inclusion  of  diverse  populations  rather  than  its  size; 
after  downsampling  the  reference  panel  to  be  the  same  size  as  T1DGC  (N=5,225),  there  was 
still  a  three-fold  increase  in  observed  alleles  ( Figure  3a ).  
 
To  empirically  assess  imputation  accuracy  of  our  reference  panel,  we  first  used  the  publicly 
available  gold-standard  HLA  types  (HLA- A ,  - B ,- C ,  - DRB1  and  - DQB1 )  of  1,267  diverse  samples 
from  AA,  EAS,  EUR  and  LAT  included  in  1KG.  We  removed  955  overlapping  samples  within  the 
reference  panel,  and  to  ensure  a  representative  analysis  we  kept  6,007  markers  overlapping 
with  the  Global  Genotyping  Array  SNPs.  Across  the  five  genes,  the  average  G-group  resolution 
accuracies  were  94.2%,  93.7%,  97.8%  and  93.7%  in  AA,  EAS,  EUR  and  LAT  ( Figure  3b-c , 
Supplementary  Table  8 ,  Methods ,  Extended  Data  3 ).  Compared  to  the  T1DGC  panel,  our 
multi-ethnic  reference  panel  showed  the  most  improvement  for  individuals  of  non-European 
descent;  we  obtained  4.27%,  2.96%,  2.90%  and  1.05%  improvement  at  G-group  resolution  for 
AA,  EAS,  LAT,  and  EUR  individuals,  respectively  ( Figure  3d ).  Increased  diversity  was 
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responsible  for  the  improvement;  downsampling  the  reference  panel  be  the  same  size  as  the 
T1DGC  panel  still  yielded  superior  performance  ( Figure  3d ).  To  validate  our  panel  further,  we 
imputed  HLA  alleles  into  a  multi-ethnic  cohort  of  2,291  individuals  from  the  Genotype  and 
Phenotype  (GaP)  registry  genotyped  on  the  ImmunoChip  array.  We  obtained  SBT  HLA  type 
information  for  six  classical  class  I  and  class  II  loci  (HLA- A ,  - B ,  - C ,  - DQA1 ,  - DQB1 ,  - DRB1 )  in  75 
samples  with  diverse  ancestral  background  (25  EUR,  25  EAS  and  25  AA,  Supplementary 
Figure  15 ,  Methods ).  Average  accuracies  were  99.0%,  95.7%  and  97.0%  for  EUR,  EAS  and 
AA  respectively  when  comparing  SBT  HLA  alleles  at  G-group  resolution  ( Methods ,  Extended 
Data  3 ).  Similar  to  the  1KG  analysis,  the  multi-ethnic  reference  panel  showed  significant 
improvement  for  individuals  with  non-European  descent  (6.3%  and  11.1%  improvement  for  EAS 
and  African  individuals  respectively  at  G-group  resolution),  and  a  more  modest  2%  improvement 
in  EUR  ( Supplementary  Figure  16 ,  Supplementary  Table  9 ).  
Fine-mapping  causal  variants  of  HIV  jointly  in  three  populations  in  the  MHC  region 
Next  we  investigated  MHC  effects  within  human  immunodeficiency  virus  type  1  (HIV-1)  set  point 
viral  load.  Upon  primary  infection  with  HIV-1,  t he  set  point  viral  load  is  reached  after  the  immune 
system  has  developed  specific  cytotoxic  T  lymphocytes  (CTL)  that  are  able  to  partially  control 
the  virus.  It  has  been  well-established  that  the  set  point  viral  load  (spVL)  varies  in  the  infected 
population  and  positively  correlates  with  rate  of  disease  progression 49 .  Previous  studies 
suggested  that  HIV-1  infection  has  a  strong  genetic  component,  and  specific  HLA  class  I  alleles 
explain  the  majority  of  genetic  risk 10,50 .  The  existence  of  multiple  independent,  ancestry-specific, 
risk-associated  alleles  has  been  reported  in  both  European 1,10   and  African  American 16  
populations.  However,  without  a  multi-ethnic  reference  panel  it  has  not  been  possible  to 
determine  if  these  signals  are  consistent  across  different  ancestral  groups. 
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To  define  the  MHC  allelic  effects  shared  across  multiple  populations,  we  applied  our  multi-ethnic 
MHC  reference  panel  to  7,445  EUR,  3,901  AA  and  677  LAT  HIV-1  infected  subjects  ( Methods , 
Supplementary  Table  10 ).  Imputation  resulted  in  640  classical  HLA  alleles,  4,513  amino  acids 
in  HLA  proteins  and  49,321  SNPs  in  the  extended  MHC  region  for  association  and  fine-mapping 
analysis.  We  confirmed  96.6%  imputation  accuracy  of  two-field  (or  four-digit)  resolution  with  a 
minor  allele  frequency  >  0.5%  in  this  cohort  by  comparing  imputed  classical  alleles  to  the  SBT 
alleles  in  a  subset  of  1,067  AA  subjects 16 ( Supplementary  Figure  17 ,  Extended  Data  3 ). 
 
We  next  tested  SNPs,  amino  acid  positions  and  classical  HLA  alleles  across  the  MHC  for 
association  to  spVL.  We  performed  this  jointly  in  EUR,  AA  and  LAT  population  using  a  linear 
regression  model  with  sex,  principal  components  and  ancestry  as  covariates  ( Methods ).  In 
agreement  with  previous  studies,  we  found  the  strongest  spVL-associated  classical  HLA  allele 
is  B*57  (effect  size  =  -0.84,  ).  This  corresponded  to  a  single  residue  Val97 .68 0  P binary = 8 × 1
­144
in  HLA-B  that  tracks  almost  perfectly  with  B*57  ( )  and  showed  the  strongest .995r2 = 0
association  of  any  single  residue  (effect  size  =  -0.84,  ,  Supplementary .99 0  P binary = 5 × 1
­145
Figure  18 ).  
 
Then  to  determine  which  amino  acid  positions  have  independent  association  with  spVL,  we 
tested  each  of  the  amino  acid  positions  by  grouping  haplotypes  carrying  a  specific  residue  at 
each  position  in  an  additive  model 2,9   ( Methods ).  We  found  the  strongest  spVL-associated  amino 
acid  variant  in  HLA-B  is  as  previously  reported 1,10,16   at  position  97  ( Figure  4a-b ,  Supplementary 
Table  11 )  which  strikingly  explains  9.06%  of  the  phenotypic  variance.  Position  97  in  HLA-B  was 
more  significant  ( )  than  any  single  SNP  or  classical  HLA  allele,  including .86 0  P omnibus = 2 × 1
­184
10 
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B*57  ( Supplementary  Figure  18 ,  Extended  Data  4 ).  Of  the  six  allelic  variants 
(Val/Asn/Trp/Thr/Arg/Ser)  at  this  position,  the  Val  residue  conferred  the  strongest  protective 
effect  (effect  size  =  -0.88,  ,  Supplementary  Figure  19 )  relative  to  the  most .32 0  P = 9 × 1 ­152
common  residue  Arg  (frequency  =  47.8%).  All  six  amino  acid  alleles  have  consistent 
frequencies  and  effect  sizes  across  the  three  population  groups  ( Figure  5a-b ,  Supplementary 
Figure  20 ).  
 
We  next  wanted  to  test  whether  there  were  other  independent  effects  outside  of  position  97  in 
HLA-B.  After  accounting  for  the  effects  of  amino  acid  97  in  HLA-B  using  a  conditional  haplotype 
analysis  ( Methods ),  we  observed  a  significant  independent  association  at  position  67  in  HLA-B 
( ,  Figure  4c-d ,  Supplementary  Table  11 ).  Considering  this  might  be  an .82 0  P omnibus = 2 × 1
­39
artifact  of  forward  search,  we  exhaustively  tested  all  possible  pairs  of  polymorphic  amino  acid 
positions  in  HLA-B.  Of  7,260  pairs  of  amino  acid  positions,  none  obtained  a  better 
goodness-of-fit  than  the  pair  of  positions  97  and  67,  which  collectively  explained  11.2%  variance 
in  spVL  ( Figure  5e ,  Supplementary  Table  12 ).  At  position  67,  Met67  residue  shows  the  most 
protective  effect  (effect  size  =  -0.44,  )  among  the  five  possible  amino  acids .19 0  P = 1 × 1 ­59
(Cys/Phe/Met/Ser/Tyr)  relative  to  the  most  common  residue  Ser  (frequency  =10.0%).  
 
Conditioning  on  positions  97  and  67  revealed  an  additional  association  at  position  156  in  HLA-B 
( ,  Figure  4e-f ,  Supplementary  Table  11 ).  In  agreement  with  the .92 0  P omnibus = 1 × 1
­30
stepwise  conditional  analysis,  when  we  tested  all  287,980  possible  combinations  of  three  amino 
acid  positions  in  HLA-B,  the  most  statistically  significant  combination  of  amino  acids  sites  is  67, 
97  and  156  ( ,  Supplementary  Table  13 ).  These  three  positions  explained .68 0  P = 5 × 1 ­244
12.9%  of  the  variance  ( Figure  5e ).  At  position  156,  residue  Arg  shows  the  largest  risk  effect 
11 
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(effect  size  =  0.180,  )  among  the  four  possible  allelic  variants .92 0  P = 8 × 1 ­14
(Leu/Arg/Asp/Trp),  relative  to  the  most  common  residue  Leu  (frequency  =  35.1%).  
 
These  amino  acid  positions  mark  three  consecutive  pockets  within  the  HLA-B  peptide-binding 
groove  ( Figure  5c ) .  Position  97  is  located  in  the  C-pocket  and  has  an  important  role  in 
determining  the  specificity  of  the  peptide-binding  groove 51,52 .  Position  67  is  in  the  B-pocket,  and 
Met 67  side  chains  occupy  the  space  where  larger  B-pocket  anchors  reside  in  other 
peptide-MHC  structures;  its  presence  limits  the  size  of  potential  peptide  position  P2  side 
chains 52 .  Amino  acid  position  156  is  part  of  the  D-pocket  and  influences  the  conformation  of  the 
peptide-binding  region 53 .  These  results  are  consistent  with  the  observation  that  in  HLA- B*57 ,  the 
single  most  protective  spVL-associated  one-field  allele  (a  single  change  at  position  156  from 
Leu  →  Arg  or  equivalently  HLA- B*57:03  →  HLA- B*57:02 )  leads  to  an  increased  repertoire  of 
HIV-specific  epitope 41,54 .  
 
Despite  differences  in  the  power  to  detect  associations  due  to  differences  in  allele  frequencies 
( Supplementary  Figure  21 ),  we  observed  generally  consistent  effects  of  individual  residues 
across  populations  ( Figure  5d,  Supplementary  Figure  22-23 ,  Supplementary  Table  14 ). 
There  are  26  unique  haplotypes  defined  by  the  amino  acids  at  positions  67,  97  and  156  in 
HLA-B  ( Table  1 ,  Supplementary  Table  15 ).  When  we  tested  for  effect  size  heterogeneity  by 
ancestry  for  each  of  these  haplotypes  ( Methods ),  we  observed  only  2  of  26  haplotypes  showed 
heterogeneity  (F-test  P-value  <  0.05/26),  possibly  due  to  different  interplay  between  genetic  and 
environmental  variation  at  population-level.  These  results  support  the  concept  that  these 
positions  mediate  HIV-1  viral  load  in  diverse  ancestries.  
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To  assess  whether  there  were  other  independent  MHC  associations  outside  HLA-B,  we 
conditioned  on  all  amino  acid  positions  in  HLA-B  and  observed  associations  at  HLA-A,  including 
at  position  77  in  HLA-A  ( ,  Figure  4g-h ,  Supplementary  Table  11 ),  the .10 0  P omnibus = 9 × 1
­7
classical  HLA  allele  HLA-A*31  ( and  the  rs2256919  promoter  SNP  ( .45 0 )  P binary = 2 × 1
­8
,  Supplementary  Figure  18 ).  These  associations  argue  for  an  effect  at   3.10 0  P binary =   × 1
­16
HLA-A,  but  larger  studies  and  functional  studies  will  be  necessary  to  define  the  driving  effects.  
Discussion 
In  our  study  we  demonstrated  accurate  imputation  with  a  single  large  reference  panel  for  HLA 
imputation.  We  have  shown  how  this  reference  panel  can  be  used  to  impute  genetic  variation  at 
eight  HLA  classical  genes  accurately  across  a  wide  range  of  populations.  Accurate  imputation  in 
multi-ethnic  studies  is  essential  for  fine-mapping.  
 
We  showed  the  utility  of  this  approach  by  defining  the  alleles  that  best  explain  HIV-1  viral  load  in 
infected  individuals.  Our  work  implicates  three  amino  acid  positions  (97,  67  and  156)  in  HLA-B 
in  conferring  the  known  protective  effect  of  HLA  class  I  variation  on  HIV-1  infection.  Combining 
all  alleles  at  these  three  positions  explained  12.9%  of  the  variance  in  spVL  ( Figure  5e ).  These 
positions  all  fall  within  the  peptide-binding  groove  of  the  respective  MHC  protein  ( Figure  5c ), 
indicating  that  variation  in  the  amino  acid  content  of  the  peptide-binding  groove  is  the  major 
genetic  determinant  of  HIV  control.  Supported  by  experimental  studies 54–57 ,  positions  highlighted 
in  our  work  indicated  a  structural  basis  for  the  HLA  association  with  HIV  disease  progression 
that  is  mediated  by  the  conformation  of  the  peptide  within  the  class  I  binding  groove.  This  result 
highlights  how  a  study  with  ancestrally  diverse  populations  can  potentially  point  to  causal 
variation  by  leveraging  linkage  disequilibrium  difference  between  ethnic  groups. 
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We  note  that  previous  studies  have  shown  position  97  in  HLA-B  has  the  strongest  association 
with  HIV-1  spVL  or  case-control  in  African  American  and  European  populations,  but  highlighted 
different  additional  signals  via  conditional  analysis  (position  45,  67  in  HLA-B  and  position  77,  95 
in  HLA-A  in  Europeans 1,10,16   and  position  63,  116  and  245  in  HLA-B  in  African  Americans 16 ). 
These  signals  do  not  explain  the  signals  we  report  here;  after  conditioning  on  positions  45,  63, 
116,  245  of  HLA-B  and  95  of  HLA-A,  the  association  of  the  four  identified  amino  acids  identified 
in  this  study  remained  significant  ( ).  In  contrast,  our  binding  groove  alleles  explain 0  P < 5 × 1 ­8
these  other  alleles;  conditioning  on  the  four  amino  acid  positions  identified  in  this  study 
(positions  67,  97  and  156  in  HLA-B),  all  previously  reported  positions  did  not  pass  the 
significance  threshold  ( ,  Supplementary  Figure  24 ). 0  P > 5 × 1 ­8  
 
Furthermore,  defining  the  effect  sizes  for  HLA  alleles  across  different  populations  is  essential  for 
defining  risk  of  a  wide-range  of  diseases  in  the  clinical  setting.  There  is  increasing  application  of 
genome-wide  genotyping  by  patients  both  by  healthcare  providers  and  direct-to-consumer 
vendors.  The  large  effects  of  the  MHC  region  for  a  wide-range  of  immune  and  non-immune 
traits,  makes  it  essential  to  define  HLA  allelic  effect  sizes  essential  in  multi-ethnic  studies  in 
order  to  build  generally  applicable  clinical  polygenic  risk  scores  for  many  diseases  in  diverse 
populations 58–61 .  Resources  like  the  one  we  present  here  will  be  an  essential  ingredient  in  such 
studies.  
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Individuals  included  in  the  reference  panel 
Study  participants  were  from  the  Jackson  Heart  Study  (JHS  ,  N = 3,027),  Multi-Ethnic  Study  of 
Atherosclerosis  (MESA,  N=4,620),  Chronic  Obstructive  Pulmonary  Disease  Gene  (COPDGene) 
study  (N=10,623) ,  Estonian  Biobank  (EST,  N=2,244),  Japan  Biological  Informatics  Consortium 
(JPN,  N=295),  Biobank  Japan  (JPN,  N=1,025)  and  1000  Genomes  Project  (1KG,  N=2,504). 
Each  study  was  previously  approved  by  respective  institutional  review  boards  (IRBs),  including 
for  the  generation  of  WGS  data  and  association  with  phenotypes.  All  participants  provided 
written  consent.  Further  details  of  cohort  descriptions  and  phenotype  definitions  are  described  in 
the  Supplementary  Note.  
HLA-TAPAS 
HLA-TAPAS  (HLA-Typing  At  Protein  for  Association  Studies)  is  an  HLA-focused  pipeline  that 
can  handle  HLA  reference  panel  construction  ( MakeReference ),  HLA  imputation  ( SNP2HLA ), 
and  HLA  association  ( HLAassoc ).  It  is  an  updated  version  of  the  SNP2HLA 48   to  build  an 
imputation  reference  panel,  perform  HLA  classical  allele,  amino  acid  and  SNP  imputation  within 
the  extended  MHC  region.  Briefly,  major  updates  include  (1)  using  PLINK1.9  ( URLs )  instead  of 
v1.07;  (2)  using  BEAGLE  v4.1  ( URLs )  instead  of  v3  for  phasing  and  imputation;  and  (3) 
including  custom  R  scripts  for  performing  association  and  fine-mapping  analysis  at  amino  acid 
level  in  multiple  ancestries.  The  source  code  is  available  for  download  ( URLs ).  
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Construction  of  a  multi-ethnic  HLA  reference  panel  using  whole-genome 
sequences 
To  construct  a  multi-ethnic  HLA  imputation  reference  panel,  we  used  24,338  whole-genome 
sequences  at  different  depths  ( Supplementary  Table  1 ).  Details  of  the  construction  using 
deep-coverage  whole-genome  sequencing  are  described  in  the  Supplementary  Note .  Briefly, 
alignment  and  variant-calling  for  genomes  sequenced  by  each  cohort  were  performed 
independently.  We  performed  local  realignment  and  quality  recalibration  with  the  Genome 
Analysis  Toolkit 62   (GATK;  version  3.6)  on  Chromosome  6:25,000,000-35,000,000.  We  detected 
single  nucleotide  variants  (SNV)  and  indels  using  GATK  with  HaplotypeCaller.  To  eliminate 
false-positive  sites  called  in  the  MHC  region,  we  restrict  our  panel  to  SNVs  reported  in  1000 
Genomes  Project 21   only. 
 
We  next  inferred  classical  HLA  alleles  at  G-group  resolution  for  eight  classical  HLA  genes 
( HLA-A ,  - B ,  - C ,  - DQA1 ,  - DQB1 ,  - DRB1 ,  -DPA1  and  - DPB1 )  using  a  population  reference 
graph 24,25 .  To  extend  the  reference  panel  versatility,  we  inferred  amino  acid  variation,  one-field 
and  two-field  resolution  alleles  from  the  inferred  G-group  alleles.  After  removing  samples  with 
low-coverage  and  failed  genome-wide  quality  control  ( Supplementary  Table  3 ),  we  constructed 
a  multi-ethnic  HLA  imputation  reference  panel  (N=21,546)  using  the  HLA-TAPAS 
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Sequence-based  typing  of  HLA  alleles 
Purified  DNA  from  the  75  donors  from  the  GaP  registry  (at  the  Feinstein  Institute  for  Medical 
Research)  was  sent  to  NHS  Blood  and  Transplant,  UK,  where  HLA  typing  was  performed. 
Next-generation  sequencing  was  done  for  HLA -A ,  -B ,  -C ,  - DQB1 ,  - DPB1  and  -DRB1 . 
PCR-sequence-specific  oligonucleotide  probe  sequencing  was  performed  for  HLA -DQA1  in  all 
samples.  These  typing  methods  yielded  classical  allele  calls  for  seven  genes  at  three-field 
(HLA- A ,  - B ,  - C  and  - DQB1 )  or  G-group  resolution  (HLA- DQA1 ,  - DPB1  and  -DRB1 ). 
 
Genomic  DNA  from  the  288  unrelated  samples  of  Japanese  ancestry  underwent  high-resolution 
allele  typing  (three-field  alleles)  of  six  classical  HLA  genes  (HLA- A ,  - B  and  - C  for  class  I;  and 
HLA- DRB1 ,  - DQA1  and  - DPB1  for  class  II) 20 .  
 
The  1000  Genomes  panel  consists  of  1,267  individuals  with  information  on  five  HLA  genes 
(HLA- A,  -B,  -C,  -DQB1 ,  and  -DRB1 )  at  G-group  resolution  among  four  major  ancestral  groups 
(AA,  EAS,  EUR  and  LAT) 7 .  
 
We  obtained  HLA  typing  of  the  1,067  African  American  subjects  included  in  the  HIV-1  viral  load 
study  as  described  previously 16,63 .  Briefly,  seven  classical  HLA  genes  (HLA- A,  -B,  -C ,  -DQA1 , 
- DQB1  - DRB1  and  -DPB1 )  were  obtained  by  sequencing  exons  2  and  3  and/or  single-stranded 
conformation  polymorphism  PCR,  and  was  provided  at  two-field  resolution.  
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Accuracy  measure  between  inferred  and  sequence-based  typing  HLA 
genotypes 
Allelic  variants  at  HLA  genes  can  be  typed  at  different  resolutions:  one-field  HLA  types  specify 
serological  activity,  two-field  HLA  types  specify  the  amino  acids  encoded  by  the  exons  of  the 
HLA  gene,  and  three-field  types  determine  the  full  exonic  sequence  including  synonymous 
variants.  G-group  resolution  determines  the  sequences  of  the  exons  encoding  the  peptide 
binding  groove,  that  is,  exons  2  and  3  for  class  I  and  exon  2  class  II  genes.  Thus,  any 
polymorphism  occurring  in  exon  4  of  class  I  gene  or  exon  3  of  class  II  gene  was  not  defined. 
This  means  many  G-group  alleles  can  map  to  multiple  three-field  and  two-field  HLA  alleles. 
 
We  calculated  the  accuracy  at  each  HLA  gene  by  summing  across  the  dosage  of  each  correctly 
inferred  HLA  allele  or  amino  acid  across  all  individuals  (N),  and  divided  by  the  total  number  of 
observations  (2*N).  That  is, 
  , ccuracy(g)A = 2N
(A )+D (A )∑
N
i
Di 1I ,g i 2i,g
where    represents  the  accuracy  at  a  classical  HLA  gene  (e.g.  HLA- B ).  ccuracy(g)A Di
represents  the  inferred  dosage  of  an  allele  in  individual  ,  and  alleles  and  represent i A1i,g A2i,g
the  true  (SBT)  HLA  types  for  an  individual  . i
 
To  evaluate  the  accuracy  between  the  inferred  and  validated  HLA  types  obtained  from  SBT  at 
G-group  resolution,  we  translated  the  highest  resolution  specified  by  the  validation  data  to  its 
matching  G-group  resolution  based  IMGT/HLA  database  (e.g.  HLA- A*01:01  → 
HLA- A*01:01:01G ),  and  compared  it  to  the  primary  output  from  HLA*LA  or  HLA-TAPAS .  We 
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also  translated  all  G-group  alleles  to  their  matching  amino  acid  sequences,  and  compared  them 
against  the  validation  alleles,  we  referred  to  this  as  the  amino  acid  level. 
 
To  evaluate  imputation  performance  in  individual  classical  HLA  alleles  and  amino  acids,  we 
calculated  the  dosage  correlation  between  imputed  and  SBT  dosage. r2  
,  r2  = y N[∑N
i=1






/ N[(∑Ni=1 xi2  ­  (∑Ni=1 xi)
2
/ ) N(∑Ni=1 yi2  ­  (∑Ni=1 yi)
2
/ )]
where  and  represents  the  inferred  and  SBT  dosage  of  an  allele  in  individual  .  xi yi i N
represents  the  number  of  individuals. 
Principal  component  analysis 
We  performed  a  principal  component  analysis  of  the  MHC  region  based  on  the 
identity-by-descent  (IBD)  distances  between  all  21,809  individuals  included  in  the  multi-ethnic 
reference  panel.  We  computed  the  IBD  distance  using  Beagle  (Version  4.1,  URLs )  and 
averaged  over  100  runs  with  all  variants  (54,474)  included  in  the  HLA  reference  panel.  Due  to 
uneven  representation  of  different  ethnicity  groups  ( Supplementary  Table  2 ),  we  applied  a 
weighted  PCA  approach,  where  mean  and  standard  deviation  of  the  IBD  matrix  within  an 
ethnicity  group  are  weighted  inversely  proportional  to  the  sample  size.  
HLA  haplotype  frequency  estimation 
We  applied  an  expectation-maximization  algorithm  approach  implemented  in  Hapl-o-Mat 64  
( URLs )  to  estimate  HLA  haplotype  frequency  based  on  eight  classical  HLA  alleles  inferred  at 
G-group  resolution.  We  estimated  haplotype  frequencies  both  overall  and  within  five  continental 
populations  ( Extended  Data  2 ).  
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Local  ancestry  inference 
To  detect  local  ancestry  in  admixed  samples,  we  first  applied  ELAI 46   to  chromosome  6  with  1000 
Genomes  Project 21   as  the  reference  panel.  We  extracted  63,998  common  HapMap3  SNPs 
between  the  WGS  (MESA  cohort)  and  the  1000  Genome  reference  panel.  We  used  the  same 
set  of  SNPs  for  ELAI  and  RFMix  analysis.  We  applied  ELAI 46   to  1,832  African  Americans  and 
594  Latinos.  For  1,832  African  American  individuals  included  in  the  study,  we  used  genotypes  of 
99  CEU  and  108  YRI  in  the  1000  Genome  Project  as  reference  panel,  assuming  admixture 
generation  to  be  seven  generations  ago.  We  used  two  upper-layer  clusters  and  10  lower-layer 
clusters  in  the  model.  For  Latinos,  we  selected  65  Latinos  with  Native  American  (NAT)  ancestry 
>  75%  included  in  the  1000  Genomes  Project  identified  using  the  ADMIXTURE  analysis 65   and 
used  these  individuals  with  high  NAT,  as  well  as  CEU  and  YRI  from  1000  Genomes  as 
reference  panels.  We  assumed  that  the  admixture  time  was  20  generations  ago.  For  ELAI,  we 
used  three  upper-layer  clusters  and  15  lower-layer  clusters  in  the  model.  
 
 
To  address  the  technical  concerns  that  local  ancestry  methods  are  biased  by  the  high  LD  of 
MHC  region 66,67 ,  we  performed  an  alternative  method,  RFMix 47 ,  for  local  ancestry  inference  that 
accounts  for  high  LD  and  lack  of  parental  reference  panels.  Similar  deviation  from  genome-wide 
ancestry  was  observed  using  RFMix  ( Supplementary  Figure  14) ,  indicating  that  the  selection 
signals  we  observed  here  are  robust  to  different  inference  methods. 
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HLA  imputation  in  the  HIV-1  viral  load  GWAS  data  in  three  populations 
We  used  genome-wide  genotyping  data  from  12,023  HIV-1  infected  individuals  aggregated 
across  more  than  10  different  cohorts  ( Supplementary  Table  10 ).  The  details  of  these  samples 
and  quality  control  procedures  have  been  described  previously 10,68 .  Using  the  HIV-1  viral  load 
GWAS  data,  we  extracted  the  genotypes  of  SNPs  located  in  the  extended  MHC  region 
(chr6:28-34Mb,  Supplementary  Table  10 ).  We  conducted  genotype  imputation  of  one-field, 
two-field  and  G-group  classical  HLA  alleles  and  amino  acid  polymorphisms  of  the  eight  class  I 
and  class  II  HLA  genes  using  the  constructed  multi-ethnic  HLA  imputation  reference  panel  and 
the  HLA-TAPAS  pipeline. 
 
After  imputation,  we  obtained  the  genotypes  of  640  classical  alleles,  4,513  amino  acid  positions 
of  the  eight  classical  HLA  genes,  and  49,321  SNPs  located  in  the  extended  MHC  region.  We 
excluded  variants  with  MAF  <  0.5%  and  imputation    for  all  association  studies.  In  total, .5r2 < 0
we  tested  51,358  variants  in  our  association  and  fine-mapping  study. 
HLA  association  analysis 
For  the  HIV-1  viral  loads  of  EUR,  AA  and  LAT  samples,  we  conducted  a  joint  haplotype-based 
association  analysis  using  a  linear  regression  model  under  the  assumption  of  additive  effects  of 
the  number  of  HLA  haplotypes  for  each  individual.  Phased  haplotypes  at  a  locus  (i.e.,  HLA 
amino  acid  position)  were  constructed  from  the  phased  imputed  genotypes  of  variants  in  the 
locus  (i.e.,  amino  acid  change  or  SNP)  and  were  converted  to  a  haplotype  matrix  where  each 
row  is  observed  haplotypes  (in  the  locus),  not  genotypes.  
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For  each  amino  acid  position,  we  applied  a  conditional  haplotype  analysis.  We  tested  a 
multiallelic  association  between  the  HIV-1  viral  load  and  a  haplotype  matrix  (of  the  position)  with 
covariates,  including  sex,  study-specific  PCs,  and  a  categorical  variable  indicating  a  population. 
That  is 
  β x c ,y =   0 + ∑
m­1
i






where  is  the  amino  acid  haplotype  formed  by  each  of  the    amino  acid  residues  that  occur  at xi m
that  position,  and    are  the  covariates  included  in  the  model. cj  
 
To  get  an  omnibus  P -value  for  each  position,  we  estimated  the  effect  of  each  amino  acid  by 
assessing  the  significance  of  the  improvement  in  fit  by  calculating  the  in-model  fit,  compared  to 
a  null  model  following  an  F-distribution  with    degrees  of  freedom.  This  is  implemented 
using  an  ANOVA  test  in  R  as  described  previously 32,69 .  The  most  frequent  haplotype  was 
excluded  from  a  haplotype  matrix  as  a  reference  haplotype  for  association. 
 
For  the  conditional  analysis ,  we  assumed  that  the  null  model  consisted  of  haplotypes  as 
defined  by  residues  at  previously  defined  amino  acid  positions.  The  alternative  model  is  in 
addition  of  another  position  with    residues.  We  tested  whether  the  addition  of  those  amino m
acid  positions,  and  the  creation  of    additional  haplotypes  groups,  improved  on  the  previous 
set.  We  then  assessed  the  significance  of  the  improvement  in  the  delta  deviance  (sum  of 
squares)  over  the  previous  model  using  an  F-test.  We  performed  stepwise  conditional  analysis 
to  identify  additional  independent  signals  by  adjusting  for  the  most  significant  amino  acid 
position  in  each  step  until  none  met  the  significance  threshold  ( ).  We  restricted 0  P = 5 × 1 ­8
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analysis  to  haplotypes  that  have  a  minimum  of  10  occurrences  within  HLA-B,  and  removed  any 
individual  with  rare  haplotypes  for  the  conditional  analysis. 
 
For  the  exhaustive  search ,  we  tested  all  possible  amino  acid  pairs  and  triplets  for  association. 
For  each  set  of  amino  acid  positions,  we  used  the  groups  of  residues  occurring  at  these 
positions  to  estimate  effect  size  and  calculated  for  each  of  these  models  the  delta  deviance  in 
risk  prediction  and  its  p-values  compared  to  the  null  model. 
Heterogeneity  testing  of  effect  sizes 
We  used  interaction  analyses  with  models  that  included  haplotype-by-ancestry  ( Haplotype  x 
Ancestry )  interaction  terms.  The  fit  of  nested  models  was  compared  to  a  null  model  using  the 
F -statistic  with  two  degrees  of  freedom,  for  which  the  association  interaction  P-value  indicated 
whether  the  inclusion  of  the  Haplotype  x  Ancestry  interaction  terms  improved  the  model  fit 
compared  to  the  null  model  that  did  not  include  the  interaction  terms.  Interaction  P-values  for  all 
haplotypes  formed  by  positions  97,  67  and  156  in  HLA-B  are  listed  in  Supplementary  Table  15 . 
Haplotypes  that  had  a  significant  Bonferroni-corrected  Haplotype  x  Ancestry  interaction 
heterogeneity  P-value  (P  <  0.05/26)  were  considered  to  show  evidence  of  significant  effect  size 
heterogeneity  between  ancestries. 
URLs 
HLA-TAPAS,  https://github.com/immunogenomics/HLA-TAPAS 
IMGT/HLA,  https://www.ebi.ac.uk/ipd/imgt/hla/; 
GATK  version  3.6,  https://software.broadinstitute.org/gatk/download/archive ; 
HLA*LA,  https://github.com/DiltheyLab/HLA-PRG-LA; 
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PLINK  1.90,  https://www.cog-genomics.org/plink2 ; 
Beagle  4.1,  https://faculty.washington.edu/browning/beagle/b4_1.html ; 
Hapl-o-Mat,  https://github.com/DKMS/Hapl-o-Mat/ ; 
1000  Genomes  gold-standard  HLA  types, 
http://ftp.1000genomes.ebi.ac.uk/vol1/ftp/data_collections/HLA_types/ 
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Figure  1.  Global  diversity  of  the  MHC  region.  ( a )  Principal  component  analysis  of  the 
pairwise  IBD  distance  between  21,546  samples  using  MHC  region  markers.  Allele  diversity  of 
( b )  HLA -B  and  ( c )  HLA- DQA1  among  five  continental  populations  (AA=Admixed  African; 
EUR=European;  LAT=Latino;  EAS=East  Asian;  SAS=South  Asian).  The  top  two  most  common 
alleles  within  each  population  group  are  named,  the  remaining  alleles  are  grouped  as  ‘others’.  
( a ) 
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Figure  2.  Pairwise  LD  and  haplotype  structure  for  six  classical  HLA  genes  in  five 
population  groups .  ( a )  shows  the  pairwise  normalized  entropy  ( )  measuring  the  difference  of ε
the  haplotype  frequency  distribution  for  linkage  disequilibrium  and  linkage  equilibrium  among 
five  population  groups.  It  takes  values  between  0  (no  LD)  to  1  (perfect  LD).  ( b )  shows  the 
haplotype  structures  of  the  eight  classical  HLA  genes  in  each  population.  The  tile  in  a  bar 
represents  an  HLA  allele,  and  its  height  corresponds  to  the  frequencies  of  the  HLA  allele.  The 
gray  lines  connecting  between  two  alleles  represent  HLA  haplotypes.  The  width  of  these  lines 
corresponds  to  the  frequencies  of  the  haplotypes.  The  most  frequent  long-range  HLA 
haplotypes  within  each  population  is  bolded  and  highlighted  in  a  color  described  by  the  key  at 
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Figure  3.  The  multi-ethnic  HLA  reference  panel  shows  improvement  in  allele  diversity  and 
imputation  accuracy.  ( a ).  The  number  of  HLA  alleles  at  the  two-field  resolution  included  in  the 
multi-ethnic  HLA  reference  panel  (N  =  21,546)  compared  to  the  European  only  Type  1  Diabetes 
Genetics  Consortium 48   (T1DGC)  panel  (N  =  5,225)  as  well  as  a  subset  of  the  multi-ethnic  HLA 
panel  down-sampled  to  the  same  size  as  T1DGC.  ( b).  The  correlation  between  imputed  and 
typed  dosages  of  classical  HLA  alleles  using  the  multi-ethnic  HLA  reference  panel  at  one-filed 
(red),  two-field  (blue)  and  G-group  resolution  (black)  of  the  955  1000  Genomes  subjects.  ( c ). 
The  imputation  accuracy  for  five  classical  HLA  genes  at  one-field,  two-field  and  G-group 
resolution.  ( d ).  The  imputation  accuracy  at  G-group  resolution  of  the  1000  Genomes  subjects 
stratified  by  four  diverse  ancestries  when  using  three  different  imputation  reference  panels  as 
described  in  ( a ). 
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Figure  4.  Stepwise  conditional  analysis  of  the  allele  and  amino  acid  positions  of  classical 
HLA  genes  to  HIV-1  viral  load.  Each  circle  point  represents  the  linear  regression  -log10( 
)  for  all  classical  HLA  alleles.  Each  diamond  point  represents  -log10( )  for  the P binary P omnibus
tested  amino  acid  positions  in  HLA  (blue=HLA- A ;  yellow=HLA- C ;  red=HLA- B ; 
lightblue=HLA- DRB1 ;  green=HLA -DQA1 ;  purple=HLA- DQB1 ,  darkgreen=HLA- DPA1 ; 
lightgreen=HLA- DPB1 ).  Association  at  amino  acid  positions  with  more  than  two  alleles  was 
calculated  using  a  multi-degree-of-freedom  omnibus  test.  The  dashed  blacked  line  represents 
the  significance  threshold  of  .  Each  panel  shows  the  association  plot  in  the  process 0  P = 5 × 1 ­8
of  stepwise  conditional  omnibus  test.  ( a )  One-field  classical  allele  B*57  ( )  and .84 0  P = 9 × 1 ­138
( b )  amino  acid  position  97  in  HLA-B  ( )  showed  the  strongest  association .86 0  P omnibus = 2 × 1
­184
signal.  Results  conditioned  on  position  97  in  HLA-B  showed  a  secondary  signal  at  ( c )  classical 
allele  B*81:0101:G  ( )  and  ( d )  position  67  in  HLA-B  ( ). .53 0  P = 4 × 1 ­23 .08 0  P omnibus = 1 × 1
­40
Results  conditioned  on  position  97  and  67  in  HLA-B  showed  the  same  classical  allele  ( e ) 
B*81:0101G  ( )  and  ( f )  third  signal  at  position  156  in  HLA-B  ( .70 0  P = 2 × 1 ­23
).  Results  conditioned  on  position  97,  67  and  156  int  HLA-B  showed  a .92 0  P omnibus = 1 × 1
­30
fourth  signal  at  ( g )  HLA -A*31  ( )  and  ( h )  position  77  in  HLA-A  ( .45 0  P = 2 × 1 ­8
)  outside  HLA-B. .35 0  P omnibus = 5 × 1
­7
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Figure  5.  Location  and  effect  of  three  independently  associated  amino  acid  positions  in 
HLA-B.  ( a )  Allele  frequency  of  six  residues  at  position  97  in  HLA-B  among  three  populations. 
( b )  Effect  on  spVL  (i.e.,  change  in  log10  HIV-1  spVL  per  allele  copy)  of  individual  amino  acid 
residues  at  position  97  in  HLA-B.  Results  were  calculated  per  allele  using  linear  regression 
models,  including  gender  and  principal  components  within  each  ancestry  as  covariates.  ( c ) 
HLA-B  (PDB  ID  code  2bvp)  proteins.  Omnibus  and  stepwise  conditional  analysis  identified  three 
independent  amino  acid  positions  (positions  97  (red),  67  (orange),  and  156  (green)  in  HLA-B. 
( d )  Effect  on  spVL  (i.e.,  change  in  log10  HIV-1  spVL  per  allele  copy)  of  individual  amino  acid 
residues  at  each  position  reported  in  this  and  previous  work 10,16 .  Results  were  calculated  per 
allele  using  linear  regression  models.  The  x-axis  shows  the  effect  size  and  its  standard  errors  in 
the  joint  analysis,  and  the  y-axis  shows  the  effect  size  and  its  standard  error  in  individual 
populations  (purple  =  Admixed  American;  blue  =  European  and  orange  =  Latino).  ( e )  Variance  of 
spVL  explained  by  the  haplotypes  formed  by  different  amino  acid  positions.  
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Table  1.  Effect  estimates  for  the  haplotypes  defined  by  the  three  independent  amino 
acids  in  HLA-B  associated  with  HIV-1  viral  load.  Only  haplotypes  with  >1%  frequency  in  the 
overall  population  are  listed  ( Supplementary  Table  15 ).  Classical  alleles  of  HLA-B  are  grouped 
based  on  the  amino  acid  residues  presented  at  position  97,  67  and  156  in  HLA-B.  For  each 
haplotype,  the  multivariate  effect  is  given  as  an  effect  size,  taking  the  most  frequent  haplotype 
(97R-67S-156L)  as  the  reference  (effect  size  =  0).  Heterogeneity  p-value  (P(het))  of  each 
haplotype  is  calculated  using  a  F-statistics  with  two  degrees  of  freedom  ( Methods ).  Effect  size 
and  its  standard  error  in  each  population  are  listed  only  for  haplotypes  that  show  evidence  of 
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